Tibet Weixinkang Medicine Co., Ltd.

603676

CNE100002QQ3

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
8.76 ^CNY	+3.30%		+13.32%	-16.01%

Apr. 25	Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Tibet Weixinkang Medicine Co., Ltd.(XSSC:603676) added to S&P Global BMI Index

September 18, 2023 at 12:00 am EDT

Latest news about Tibet Weixinkang Medicine Co., Ltd.

Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Tibet Weixinkang Medicine Co., Ltd.(XSSC:603676) added to S&P Global BMI Index	23-09-18	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Tibet Weixinkang Medicine Unit Gets Certification for Dopamine Drug in China	23-06-30	MT
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-17	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the First quarter Ended March 31, 2021	21-04-27	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-27	CI
Zhejiang China Commodities City : China stocks end higher on upbeat data	20-12-28	RE
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-28	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-26	CI
Certain A Shares of Tibet Weixinkang Medicine Co., Ltd. are subject to a Lock-Up Agreement Ending on 21-JUL-2020.	20-07-20	CI
Tibet Weixinkang Medicine Co., Ltd. Announces Implementation of Rights and Interests Distribution Per A Share for 2019, Payable on June 2, 2020	20-05-25	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-27	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-24	CI
Tibet Weixinkang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-27	CI
Tibet Weixinkang Medicine Co., Ltd. Announces Implementation of Rights and Interests Distribution for 2018, Payable on May 30, 2019	19-05-22	CI
Tibet Weixinkang Medicine Co., Ltd. Announces Earnings Results for the First Quarter of 2019	19-04-24	CI
Tibet Weixinkang Medicine Co., Ltd. Announces Earnings Results for 2018	19-04-24	CI

Chart Tibet Weixinkang Medicine Co., Ltd.

Duration

Period

Chart Tibet Weixinkang Medicine Co., Ltd.

More charts

Tibet Weixinkang Medicine Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of chemical medicines and related active pharmaceutical ingredients (APIs). The Company's main products include injection of complex vitamins, injection of potassium aspartate magnesium, sucrose iron injection and potassium aspartate injection. The Company is also engaged in the production and sales of liver protection drugs and antibiotics products. The Company mainly distributes its products in the domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
TIBET WEIXINKANG MEDICINE CO., LTD.	-16.01%	526M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B